Changjiang Pharmaceutical Group Co., Ltd. (SHE:300391)
China · Delayed Price · Currency is CNY 0.9200
+0.1500 (19.48%)
At close: Jan 23, 2026
SHE:300391 Revenue
Changjiang Pharmaceutical Group had revenue of 34.88M CNY in the quarter ending September 30, 2025, with 27.52% growth. This brings the company's revenue in the last twelve months to 116.07M, down -58.05% year-over-year. In the year 2024, Changjiang Pharmaceutical Group had annual revenue of 111.63M, down -90.68%.
Revenue (ttm)
116.07M
Revenue Growth
-58.05%
P/S Ratio
2.78
Revenue / Employee
329.75K
Employees
352
Market Cap
322.31M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 111.63M | -1.09B | -90.68% |
| Dec 31, 2023 | 1.20B | -417.76M | -25.86% |
| Jan 1, 2023 | 1.62B | -746.62M | -31.61% |
| Jan 1, 2022 | 2.36B | 1.15B | 94.48% |
| Dec 31, 2020 | 1.21B | 489.19M | 67.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hainan Huluwa Pharmaceutical Group | 1.06B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Anhui Huangshan Capsule | 471.08M |
| Guhan Pharmaceutical Group | 351.79M |